Clin Pharmacol Ther. 2011 May;89(5):662-73. doi: 10.1038/clpt.2011.34. Epub 2011 Mar 16.

Pharmacogenetics: from bench to byte--an update of guidelines.

Swen JJ, Nijenhuis M, de Boer A, Grandia L, Maitland-van der Zee AH, Mulder H, Rongen GA, van Schaik RH, Schalekamp T, Touw DJ, van der Weide J, Wilffert B, Deneer VH, Guchelaar HJ.

Source

Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Leiden, The Netherlands.

Abstract

Currently, there are very few guidelines linking the results of pharmacogenetic tests to specific therapeutic recommendations. Therefore, the Royal Dutch Association for the Advancement of Pharmacy established the Pharmacogenetics Working Group with the objective of developing pharmacogenetics-based therapeutic (dose) recommendations. After systematic review of the literature, recommendations were developed for 53 drugs associated with genes coding for CYP2D6, CYP2C19, CYP2C9, thiopurine-S-methyltransferase (TPMT), dihydropyrimidine dehydrogenase (DPD), vitamin K epoxide reductase (VKORC1), uridine diphosphate glucuronosyltransferase 1A1 (UGT1A1), HLA-B44, HLA-B*5701, CYP3A5, and factor V Leiden (FVL).

PMID:: 21412232; [PubMed - indexed for MEDLINE]

Publication Types, MeSH Terms, Substances

Publication Types

Review

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Medical

Medicines - MedlinePlus Health Information

Molecular Biology Databases

Pharmacogenomic Annotation 827859853 for PMID:21412232 [PharmGKB] - Pharmacogenomics Knowledge Base

Supplemental Content

Save items

Related citations in PubMed

Review Clinical applicability of sequence variations in genes related to drug metabolism. [Curr Drug Metab. 2011]
Review Clinical applicability of sequence variations in genes related to drug metabolism.
Stojiljkovic M, Patrinos GP, Pavlovic S. Curr Drug Metab. 2011 Jun; 12(5):445-54.
Review Genetic polymorphisms of drug-metabolising enzymes and drug transporters in the chemotherapeutic treatment of cancer. [Clin Pharmacokinet. 2006]
Review Genetic polymorphisms of drug-metabolising enzymes and drug transporters in the chemotherapeutic treatment of cancer.
Bosch TM, Meijerman I, Beijnen JH, Schellens JH. Clin Pharmacokinet. 2006; 45(3):253-85.
Characterization of 107 genomic DNA reference materials for CYP2D6, CYP2C19, CYP2C9, VKORC1, and UGT1A1: a GeT-RM and Association for Molecular Pathology collaborative project. [J Mol Diagn. 2010]
Characterization of 107 genomic DNA reference materials for CYP2D6, CYP2C19, CYP2C9, VKORC1, and UGT1A1: a GeT-RM and Association for Molecular Pathology collaborative project.
Pratt VM, Zehnbauer B, Wilson JA, Baak R, Babic N, Bettinotti M, Buller A, Butz K, Campbell M, Civalier C, et al. J Mol Diagn. 2010 Nov; 12(6):835-46. Epub 2010 Oct 1.
Review Clinical pharmacogenetics and potential application in personalized medicine. [Curr Drug Metab. 2008]
Review Clinical pharmacogenetics and potential application in personalized medicine.
Zhou SF, Di YM, Chan E, Du YM, Chow VD, Xue CC, Lai X, Wang JC, Li CG, Tian M, et al. Curr Drug Metab. 2008 Oct; 9(8):738-84.
Review Pharmacogenetic testing: time for clinical practice guidelines. [Clin Pharmacol Ther. 2011]
Review Pharmacogenetic testing: time for clinical practice guidelines.
Amstutz U, Carleton BC. Clin Pharmacol Ther. 2011 Jun; 89(6):924-7. Epub 2011 Apr 20.

See reviews... See all...

Cited by 14 PubMed Central articles

Scientific challenges and implementation barriers to translation of pharmacogenomics in clinical practice. [ISRN Pharmacol. 2013]
Scientific challenges and implementation barriers to translation of pharmacogenomics in clinical practice.
Lam YW. ISRN Pharmacol. 2013; 2013:641089. Epub 2013 Feb 28.
Multilocus genotypes of relevance for drug metabolizing enzymes and therapy with thiopurines in patients with acute lymphoblastic leukemia. [Front Genet. 2012]
Multilocus genotypes of relevance for drug metabolizing enzymes and therapy with thiopurines in patients with acute lymphoblastic leukemia.
Stocco G, Franca R, Verzegnassi F, Londero M, Rabusin M, Decorti G. Front Genet. 2012; 3:309. Epub 2013 Jan 7.
Toward a clinical practice guide in pharmacogenomics testing for functional polymorphisms of drug-metabolizing enzymes. Gene/drug pairs and barriers perceived in Spain. [Front Genet. 2012]
Toward a clinical practice guide in pharmacogenomics testing for functional polymorphisms of drug-metabolizing enzymes. Gene/drug pairs and barriers perceived in Spain.
Agúndez JA, Abad-Santos F, Aldea A, Alonso-Navarro H, Bernal ML, Borobia AM, Borrás E, Carballo M, Carvajal A, García-Muñiz JD, et al. Front Genet. 2012; 3:273. Epub 2012 Nov 26.

See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.
Cited in Books
NCBI Bookshelf books that cite the current articles.

Recent activity

Clear Turn Off Turn On

Pharmacogenetics: from bench to byte--an update of guidelines.
Pharmacogenetics: from bench to byte--an update of guidelines.
Clin Pharmacol Ther. 2011 May ;89(5):662-73. doi: 10.1038/clpt.2011.34. Epub 2011 Mar 16 .

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to: